AxoGen Inc. (NASDAQ:AXGN) – Analysts at Wedbush dropped their FY2018 earnings estimates for AxoGen in a report released on Monday. Wedbush analyst Levy. T now anticipates that the brokerage will earn $0.11 per share for the year, down from their prior forecast of $0.12. Wedbush currently has a “Outperform” rating and a $10.00 target price on the stock. Wedbush also issued estimates for AxoGen’s FY2019 earnings at $0.52 EPS.

AxoGen (NASDAQ:AXGN) last posted its earnings results on Wednesday, August 3rd. The company reported ($0.09) EPS for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.03. AxoGen had a negative net margin of 37.90% and a negative return on equity of 193.60%.

Earnings History and Estimates for AxoGen (NASDAQ:AXGN)

AxoGen (NASDAQ:AXGN) traded up 1.71% during midday trading on Wednesday, reaching $8.90. 73,134 shares of the company’s stock were exchanged. AxoGen has a 12-month low of $4.08 and a 12-month high of $9.88. The stock’s 50-day moving average is $8.73 and its 200-day moving average is $7.06. The stock’s market capitalization is $268.17 million.

In other AxoGen news, Director Amy Mcbride Wendell purchased 13,333 shares of the stock in a transaction dated Friday, October 7th. The stock was purchased at an average price of $7.50 per share, with a total value of $99,997.50. Following the transaction, the director now owns 13,333 shares of the company’s stock, valued at $99,997.50. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP John P. Engels purchased 4,000 shares of the stock in a transaction dated Friday, October 7th. The stock was acquired at an average cost of $7.50 per share, with a total value of $30,000.00. Following the transaction, the vice president now directly owns 98,425 shares in the company, valued at approximately $738,187.50. The disclosure for this purchase can be found here. 9.33% of the stock is currently owned by insiders.

Large investors have recently made changes to their positions in the company. California State Teachers Retirement System acquired a new stake in shares of AxoGen during the second quarter valued at $348,000. Bank of New York Mellon Corp boosted its stake in shares of AxoGen by 196.8% in the second quarter. Bank of New York Mellon Corp now owns 80,580 shares of the company’s stock valued at $555,000 after buying an additional 53,427 shares during the last quarter. UBS Group AG boosted its stake in shares of AxoGen by 991.7% in the first quarter. UBS Group AG now owns 97,946 shares of the company’s stock valued at $525,000 after buying an additional 88,974 shares during the last quarter. Waddell & Reed Financial Inc. acquired a new stake in shares of AxoGen during the second quarter valued at $1,371,000. Finally, State Street Corp acquired a new stake in shares of AxoGen during the second quarter valued at $1,885,000. 57.87% of the stock is owned by hedge funds and other institutional investors.

5 Day Chart for NASDAQ:AXGN

Receive News & Stock Ratings for AxoGen Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AxoGen Inc. and related stocks with our FREE daily email newsletter.